» Articles » PMID: 17517690

A Common Polymorphism Decreases Low-density Lipoprotein Receptor Exon 12 Splicing Efficiency and Associates with Increased Cholesterol

Overview
Journal Hum Mol Genet
Date 2007 May 23
PMID 17517690
Citations 50
Authors
Affiliations
Soon will be listed here.
Abstract

Single nucleotide polymorphisms (SNPs) that alter exon splicing efficiency are an emerging class of functional genetic variants. Since mutations in low-density lipoprotein receptor (LDLR) are a primary cause of familial hypercholesterolemia, we evaluated whether LDLR SNPs may alter splicing efficiency and cholesterol homeostasis. A SNP within LDLR exon 12, rs688, was identified in silico as neutralizing a putative exon splicing enhancer. Studies in human liver samples established that this SNP was associated with significantly decreased LDLR exon 12 splicing efficiency in women in vivo. In vitro minigene splicing studies qualitatively replicated these in vivo results and demonstrated that rs688 specifically modulates splicing efficiency. These effects on splicing may be physiologically relevant because the presence of the rs688 minor allele associates with increased total and LDL-cholesterol in female members of the Framingham Offspring Study. The largest rs688-associated cholesterol differences were observed in pre-menopausal women. In summary, these studies identify an LDLR SNP present in approximately 60% of Caucasians that is associated with significant 10% increases in total and LDL-cholesterol in pre-menopausal women.

Citing Articles

Association of Gene Polymorphism with the Risk of Cardiovascular Disease in End-Stage Kidney Disease Patients on Maintenance Hemodialysis.

Osman E, Shawky H, Abbas R, Metwaly A, Ibrahim A, Khanany F Indian J Nephrol. 2025; 35(1):29-33.

PMID: 39872263 PMC: 11763009. DOI: 10.25259/IJN_33_2024.


The association between polymorphism of LDL-R gene and ischemic stroke risk in Chinese population: A meta-analysis.

Dai Z, Wang Y, Li P, Zhang H, Gou X Heliyon. 2024; 10(4):e26314.

PMID: 38390048 PMC: 10881424. DOI: 10.1016/j.heliyon.2024.e26314.


APOE genetics influence murine gut microbiome.

Zajac D, Green S, Johnson L, Estus S Sci Rep. 2022; 12(1):1906.

PMID: 35115575 PMC: 8814305. DOI: 10.1038/s41598-022-05763-1.


Alternative Splicing in Cardiovascular Disease-A Survey of Recent Findings.

Hasimbegovic E, Schweiger V, Kastner N, Spannbauer A, Traxler D, Lukovic D Genes (Basel). 2021; 12(9).

PMID: 34573439 PMC: 8469243. DOI: 10.3390/genes12091457.


LDLR gene polymorphism (rs688) affects susceptibility to cardiovascular disease in end-stage kidney disease patients.

Buraczynska M, Jacob J, Gwiazda-Tyndel K, Ksiazek A BMC Nephrol. 2021; 22(1):316.

PMID: 34556050 PMC: 8459523. DOI: 10.1186/s12882-021-02532-6.


References
1.
Fu Y, Katsuya T, Higaki J, Asai T, Fukuda M, Takiuchi S . A common mutation of low-density lipoprotein receptor gene is associated with essential hypertension among Japanese. J Hum Hypertens. 2001; 15(2):125-30. DOI: 10.1038/sj.jhh.1001132. View

2.
Tveten K, Ranheim T, Berge K, Leren T, Kulseth M . Analysis of alternatively spliced isoforms of human LDL receptor mRNA. Clin Chim Acta. 2006; 373(1-2):151-7. DOI: 10.1016/j.cca.2006.05.031. View

3.
Cartegni L, Chew S, Krainer A . Listening to silence and understanding nonsense: exonic mutations that affect splicing. Nat Rev Genet. 2002; 3(4):285-98. DOI: 10.1038/nrg775. View

4.
Knoblauch H, Bauerfeind A, Krahenbuhl C, Daury A, Rohde K, Bejanin S . Common haplotypes in five genes influence genetic variance of LDL and HDL cholesterol in the general population. Hum Mol Genet. 2002; 11(12):1477-85. DOI: 10.1093/hmg/11.12.1477. View

5.
Fairbrother W, Yeh R, Sharp P, Burge C . Predictive identification of exonic splicing enhancers in human genes. Science. 2002; 297(5583):1007-13. DOI: 10.1126/science.1073774. View